11/3
08:03 am
mgnx
MacroGenics (NASDAQ:MGNX) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
Medium
Report
MacroGenics (NASDAQ:MGNX) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.